Not at all, I think it was news to all of us but a quick google showed that study from a year ago. Clearly an issue to keep an eye on for people who they describe as "chronic" users of oral PPS but from my reading the researchers are recommending more informed regular eye exams for long-term users, for users with the condition to look for an alternative treatment, and for new users to be screened for existing eye conditions. It joins a long list of possible side effects, as per all drugs.
research reports and media, page-237
-
- There are more pages in this discussion • 4,192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.015(6.98%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.0¢ | $201.6K | 994.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 429247 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 13806 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |